IL33 and acute lymphoblastic leukemia: Although it is not feasible to determine whether the anti-apoptotic role of IL-33/p38 MAPK pathway is applicable to all subtypes of ALL, our data provide fundamental data and the basis for further investigations on the biological mechanisms associated with IL-33/p38 MAPK signalling during ALL maintenance.